Related scientific articles (all)

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease.

Authors : Danlos FX, Voisin AL, Dyevre V, Michot JM, Routier E, Taillade L, Champiat S, Aspeslagh S, Haroche J, Albiges L, Massard C, Girard N, Dalle S, Besse B, Laghouati S, Soria JC, Mateus C, Robert C, Lanoy E, Marabelle A, Lambotte O
Year : 2018
Journal : Eur J Cancer
Volume : 91
Pages : 21-29

Reply to ESMO-MCBS v1.1: Statistical and Patient Relevant Shortcomings" by R. Emprechtinger et al."

Authors : Cherny NI, Dafni U, Piccart-Gebhart M, Latino NJ, Douillard JY, Bogaerts J, Karlis D, Zygoura P, Pentheroudakis G, Tabernero J, Zielinski C, de Vries EGE
Year : 2018
Journal : Ann Oncol
Volume : 29(5)
Pages : 1335-1338

Supportive care in the era of immunotherapies for advanced non-small-cell lung cancer.

Authors : Awada G, Klastersky J
Year : 2018
Journal : Curr Opin Oncol
Volume : 30(2)
Pages : 98-104

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

Authors : Bidard FC, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, Naume B, Horiguchi J, Gisbert-Criado R, Sleijfer S, Toi M, Garcia-Saenz JA, Hartkopf A, Generali D, Rothé F, Smerage J, Muinelo-Romay L, Stebbing J, Viens P, Magbanua MJM, Hall CS, Engebraaten O, Takata D, Vidal-Martínez J, Onstenk W, Fujisawa N, Diaz-Rubio E, Taran FA, Cappelletti MR, Ignatiadis M, Proudhon C, Wolf DM, Bauldry JB, Borgen E, Nagaoka R, Carañana V, Kraan J, Maestro M, Brucker SY, Weber K, Reyal F, Amara D, Karhade MG, Mathiesen RR, Tokiniwa H, Llombart-Cussac A, Meddis A, Blanche P, dHollander K, Pantel K
Year : 2018
Journal : J Natl Cancer Inst
Volume : 110(6)
Pages : 560-567

CDK4/6 inhibitors as neoadjuvant treatment in breast cancer - what can we learn?

Authors : Brandão M, Ignatiadis M
Year : 2018
Journal : Ann Oncol
Volume : 29(12)
Pages : 2274-2278

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.(autors : Early Breast Cancer Trialists'Collaborative Group)

Authors : Early Breast Cancer Trialists Collaborative Group, + collaborators (among others :, Piccart-Gebhart M
Year : 2018
Journal : Lancet Oncol
Volume : 19
Pages : 27-39

A rare case of hepatotoxicity in geriatrics.

Authors : El Kahi C, Martinet V, Praet JP, Pepersack T
Year : 2018
Journal : Rev Med Brux
Volume : 39
Pages : 164-165

Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer.

Authors : Basaran G, Twelves C, Diéras V, Cortés J, Awada A
Year : 2018
Journal : Cancer Treat Rev
Volume : 63
Pages : 144-155

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?

Authors : Lambertini M, Viglietti G, de Azambuja E
Year : 2018
Journal : ESMO Open
Volume : 3
Pages : e000350

Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinati

Authors : Rapoport BL, Aapro M, Paesmans M, van Eeden R, Smit T, Krendyukov A, Klastersky J
Year : 2018
Journal : BMC Cancer
Volume : 18
Pages : 917

Retroperitoneal mixed malignant mullerian tumor : exceptional localisation and prognosis.

Authors : El Hachem G, Jungels C, Larsimont D, Awada A
Year : 2018
Journal : Rev Med Brux
Volume : 39
Pages : 146-149

Celyad's novel CAR T-cell therapy for solid malignancies.

Authors : Lonez C, Hendlisz A, Shaza L, Aftimos P, Vouche M, Donckier V, Machiels JH, Van den Eynde M, Canon JL, Carrasco J, Odunsi K, Sahebjam S, Rottey S, Braun N, Verma B, Gilham DE, Lehmann FF
Year : 2018
Journal : Curr Res Transl Med
Volume : 66(2)
Pages : 53-56

Development of the Multi-Dimensional Analysis of Patient Outcome Predictions (MD.POP) during medical encounters.

Authors : Ménard C, Libert Y, Canivet D, Van Achte L, Farvacques C, Liénard A, Merckaert I, Reynaert C, Slachmuylder JL, Durieux JF, Klastersky J, Razavi D
Year : 2018
Journal : Patient Educ Couns
Volume : 101(1)
Pages : 52-58

Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2.

Authors : Campone M, Im SA, Iwata H, Clemons M, Ito Y, Awada A, Chia S, Pistilli B, Tseng LM, Hurvitz S, Masuda N, Cortés J, De Laurentiis M, Arteaga CL, Jiang Z, Jonat W, Le Mouhaër S, Sankaran B, Bourdeau L, El-Hashimy M, Sellami D, Baselga J
Year : 2018
Journal : Eur J Cancer
Volume : 103
Pages : 147-154

Early postsurgical temozolomide treatment in newly diagnosed bad prognosis glioblastoma patients: Feasibility study.

Authors : Chaskis E, Luce S, Goldman S, Sadeghi N, Melot C, De Witte O, Devriendt D, Lefranc F
Year : 2018
Journal : Bull Cancer
Volume : 105
Pages : 664-670

Network science in clinical trials: A patient-centered approach.

Authors : Manem VSK, Salgado R, Aftimos P, Sotiriou C, Haibe-Kains B
Year : 2018
Journal : Semin Cancer Biol
Volume : 52
Pages : 135-150

Total choline quantification measured by 1H MR spectroscopy as early predictor of response after neoadjuvant treatment for locally advanced breast cancer: The impact of immunohistochemical status.

Authors : Drisis S, Flamen P, Ignatiadis M, Metens T, Chao SL, Chintinne M, Lemort M
Year : 2018
Journal : J Magn Reson Imaging
Volume : 48(4)
Pages : 982-993

In Reply to Belkacemi and Tsoutsou.

Authors : Zeidan YH, Habib JG, de Azambuja E, Campbell I, Andersson M, Lluch A, Di Leo A, Francis PA
Year : 2018
Journal : Int J Radiat Oncol Biol Phys
Volume : 102
Pages : 467-468

Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis.

Authors : Poggio F, Bruzzone M, Ceppi M, Conte B, Martel S, Maurer C, Tagliamento M, Viglietti G, Del Mastro L, de Azambuja E, Lambertini M
Year : 2018
Journal : ESMO Open
Volume : 3
Pages : e000361

Choice of chemotherapy regimen for early HER2-positive breast cancer in elderly patients.

Authors : Pondé N, de Azambuja E
Year : 2018
Journal : Chin Clin Oncol
Volume : 7(1)
Pages : 4